Health Condition 1: K30- Functional dyspepsia Health Condition 2: K25- Gastric ulcer Health Condition 3: K297- Gastritis, unspecified Health Condition 4: K21- Gastro-esophageal reflux disease
Conditions
Interventions
Intervention1: Troxip: Troxipide 100 mg orally once a day for 28 days
Control Intervention1: Not Applicable: Not Applicable
Sponsors
Zuventus Healthcare Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and Female adult patients. 2. Patients need to be prescribed TroxipTM in order to be enrolled in the surveillance program. 3. Patients of acid-peptic disorders. (Acid peptic disorders are defined as the diseases of either acute or chronic occurrence in the oesophagus, stomach or duodenum. These anatomical gastro-intestinal organs are affected due to the excess acid secretion, which on symptomatic presentation as pain and discomfort by the patients are classified as acid peptic disease). 4. Any other patient to be prescribed TroxipTM as per prescribing information or as per prescribing physicianâ??s discretion.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety and TolerabilityTimepoint: for 28 days | — |
Secondary
| Measure | Time frame |
|---|---|
| EfficacyTimepoint: 28 days;patient complianceTimepoint: 28 days | — |
Countries
India
Contacts
Public ContactDr Bhupesh Dewan
Zuventus Healthcare Ltd
Outcome results
None listed